Skip to main content
. 2017 Dec 11;110(5):493–500. doi: 10.1093/jnci/djx239

Figure 4.

Figure 4.

Medical oncologists’ perspectives on recommending chemotherapy and ordering genomic testing in response to patient preference and genomic results for (A) node-negative and (B) node-positive disease.